Thesis check
- Buyers stepping in ahead of the report, shares up 2.8% to $8.37
- Management guided to positive comparable sales for the rest of fiscal 2026 and over $100 million in full-year free cash flow
- Call-heavy options positioning at a 0.43 put/call ratio
- Q4 2026 EPS of -$0.35 against a $0.46 estimate, with revenue of $530 million missing a $555 million bar
- Shares down 23.2% since that last report and 48% year to date
- Polymarket traders at just 51% odds of a beat, drifting lower this week
- Market cap shrunk to roughly $293 million
The load-bearing piece is comparable sales turning positive, and after last quarter's revenue shortfall that is the one promise tonight has to validate. As we noted at 1:48 p.m. ET, traders extended management credit on the last report and then pulled it back over the following months. Positive comps plus a reaffirmed free cash flow target would flip this back to intact.








